Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06260774 · ClinicalTrials.gov registry record · Phase 1

Study of TTX-MC138 in Subjects With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by TransCode Therapeutics.

Active
Registry status
Phase 1
Development phase
16
Enrollment target
4
Study locations

NCT06260774 is a Phase 1 study of Advanced Solid Tumor that is active but no longer recruiting, run by TransCode Therapeutics. The registered enrollment target is 16 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06260774, a Phase 1 study of Advanced Solid Tumor, is active but no longer recruiting, sponsored by TransCode Therapeutics.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
16 participants
Enrollment target
4
Study locations

Study Summary

A Phase 1/2 Multicenter, Open-Label, Dose-Escalation and Expansion Study of TTX MC138 in Subjects with Advanced Solid Tumors

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG TTX-MC138

Study Locations (4)

Texas

  • Mary Crowley Cancer Center - Dallas
  • MD Anderson Cancer Center - Houston

Utah

  • START Mountain Region - West Valley City

Virginia

  • Next Oncology - Fairfax

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2024-09-05
Est. Completion 2027-02-01
Phase Phase 1

Sponsor

TransCode Therapeutics

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06260774

The ClinicalTrials.gov registry entry for NCT06260774 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (92% lower). The listed sponsor is TransCode Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which TTX-MC138 is the first listed.

NCT06260774 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Texas, Utah, Virginia.

Frequently Asked Questions

What is clinical trial NCT06260774 about?

NCT06260774 is a clinical study titled "Study of TTX-MC138 in Subjects With Advanced Solid Tumors". A Phase 1/2 Multicenter, Open-Label, Dose-Escalation and Expansion Study of TTX MC138 in Subjects with Advanced Solid Tumors

What is the current status of trial NCT06260774?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2024-09-05. Estimated completion is 2027-02-01.

What conditions does trial NCT06260774 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT06260774?

The interventions under investigation include: TTX-MC138 (DRUG).

Who is sponsoring clinical trial NCT06260774?

This trial is sponsored by TransCode Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06260774 being conducted?

This trial has 4 study locations across Texas, Utah, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.